Physician profile
Patrick N Brown
NPI 1528069325
$4,368.73
in general payments reported to CMS, 2019-2025
18 companies · $2,401 in 2025
The $2,401 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $107 · 2021: $93.13 · 2022: $347 · 2023: $348 · 2024: $823 · 2025: $2,401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,571.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,423.63 | 2022-2025 | Inspire |
| Genzyme Corporation | $816.93 | 2022-2025 | |
| Glaxosmithkline, LLC. | $515.27 | 2024-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $508.82 | 2021-2025 | Dupixent |
| Livanova USA, INC. | $291.75 | 2019-2020 | |
| Medtronic, INC. | $269.00 | 2025 | Propel, Sinuva, Nuvent |
| Lilly USA, LLC | $148.78 | 2025 | Zepbound |
| Aerin Medical INC. | $148.60 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $43.04 | 2021 | |
| 3b Medical, INC. | $34.93 | 2025 | Luna |
| Optinose US, INC. | $32.81 | 2020 | |
| Integra Lifesciences Corporation | $30.23 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Zoll Respicardia, INC. | $24.50 | 2024 | Remede System |
| Intersect Ent, INC. | $20.35 | 2019 | |
| Fisher & Paykel Healthcare INC | $17.44 | 2023 | Fisher & Paykel Healthcare |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $15.72 | 2025 | |
| Tactile Systems Technology INC | $14.89 | 2024 | Flexitouch Plus, Entre Plus |
| Almirall LLC | $12.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.